Cancer Gene Therapy

Cancer therapies are drugs or other substances that block the growth and spread of cancer by interfering with specific molecules ("molecular targets") that are involved in the growth, progression, and spread of cancer. Many cancer therapies have been approved by the Food and Drug Administration (FDA) to treat specific types of cancer. The development of targeted therapies requires the identification of good targets that is, targets that play a key role in cancer cell growth and survival. One approach to identify potential targets is to compare the amounts of individual proteins in cancer cells with those in normal cells.  Proteins that are present in cancer cells but not normal cells or that are more abundant in cancer cells would be potential targets, especially if they are known to be involved in cell growth or survival.

Related Conferences: International Conference on Cervical Cancer, 22-23 September, 2016 (Vienna, Austria); 6th World Congress on Cancer Therapy, 01-03 December, 2016 (Baltimore, USA); 13th Global Summit on Cancer Therapy 17-19 October, 2016 (Dubai, UAE); International Conference on Pancreatic and Colorectal Cancer, 29-30 March, 2016 (Atlanta, USA); Global Summit on Melanoma And Carcinoma, 14-15 July, 2016 (Brisbane, Australia); Chromatin and Epigenetic in Cancer ( Atlanta, Georgia); Advances in Ovarian Cancer Research: Exploiting Vulnerabilities (Orlando, Florida); Advance in Breast Cancer Research ( Washington, DC); Advances in Pediatric Cancer Research (Florida);  New Horizons in Cancer Research Conference (Sanghai, China).

Cancer occurrs by the production of multiple mutations in a single cell that causes it to proliferate out of control. Cancer cells often different from their normal neighbors by a host of specific phenotypic changes, such as rapid division rate, invasion of new cellular territories, high metabolic rate, and altered shape. Some of those mutations may be transmitted from the parents through the germ line. Others arise de novo in the somatic cell lineage of a particular cell. Cancer-promoting mutations can be identified in a variety of ways. They can be cloned and studied to learn how they can be controlled. T lymphocytes have the capacity to hone in on tumor tissue. This property has been used to deliver cytokines directly to tumor masses for human gene therapy. The secretion of cytokines locally at the tumor site by the effector T lymphocytes will enhance their anti-tumor activity and avoid the side-effects that result from the systemic administration of cytokines.

  • Gene therapy in cancer
  • Breast cancer gene therapy
  • Lung cancer gene therapy
  • Prostate cancer gene therapy
  • Pancreatic cancer gene therapy
  • Characteristics of cancer cells
  • Cell cycle & oncology
  • Modern approaches in molecular cancer therapeutics
  • Genomic & cancer drug resistance
  • Genetically engineered cancer vaccines
  • Therapeutics cancer vaccines
  • Challenges & risks of cancer gene therapy

Related Conference of Cancer Gene Therapy

September 25-27, 2017

17th Euro Biotechnology Congress

Berlin, Germany
September 27-28, 2017

Annual Summit on Cell Therapy and Molecular Medicine

(10 Plenary Forums - 1Event)
Chicago, Illinois, USA
September 27-28, 2017

Annual Summit on Cell Signaling and Cancer Therapy

(10 Plenary Forums - 1Event)
Chicago, Illinois, USA
October 19-20, 2017, Hilton New York JFK Airport Hotel

18th Biotechnology Congress

New York, USA
October 20-21, 2017

3rd World Congress on Human Genetics & Genetic Disorders

Toronto, Canada
October 23-24, 2017

10th World Congress on Stem Cell and Biobanking

Osaka, Japan
November 13-14, 2017

19th World Congress on Biotechnology

Osaka, Japan
December 04-05, 2017

2nd World Biotechnology Congress

(10 Plenary Forums - 1Event)
Sao Paulo, Brazil
December 11-12, 2017

3rd World Bio Summit & Expo

Dubai, UAE
March 5-7, 2018

20th Global Congress on Biotechnology

London, UK
April 16-18, 2018

22nd Edition of International Conference on BIOTECHNOLOGY

Amsterdam, Netherlands
April 16-17, 2018

EuroSciCon Conference on StemCell

Amsterdam, Netherlands
May 14-15, 2018

11th World Congress on Cell & Tissue Science

Tokyo, Japan
May 21-23, 2018

6th International Conference on Integrative Biology

Barcelona, Spain
July 2-3, 2018

4th International Conference on Bioscience

Vienna, Austria
July 9-10, 2018

8th World Congress on Plant Science & Genomics

Sydney, Australia
September 24-25, 2018

3rd World Congress on HUMAN GENETICS

Berlin, Germany

Cancer Gene Therapy Conference Speakers

Recommended Sessions

Related Journals

Are you interested in